Structure-Based Rationale for Interleukin 5 Receptor Antagonism

Publisher： Bentham Science Publishers

E-ISSN： 1873-4286|14|12|1231-1239

ISSN： 1381-6128

Source： Current Pharmaceutical Design, Vol.14, Iss.12, 2008-04, pp. : 1231-1239

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Structure-Based Rational Design of Adenosine Receptor Ligands

By  

Current Topics in Medicinal Chemistry, Vol. 17, Iss. 1, 2017-01 ,pp. : 40-58

Bentham Science Publishers

Access to resources Recommend Favorite

Structure-Based Development of Antagonists for Chemokine Receptor CXCR4

By  

Current Computer - Aided Drug Design, Vol. 9, Iss. 1, 2013-03 ,pp. : 60-75

Bentham Science Publishers

Access to resources Recommend Favorite

Customizing G Protein-Coupled Receptor Models for Structure-Based Virtual Screening

By  

Current Pharmaceutical Design, Vol. 15, Iss. 35, 2009-12 ,pp. : 4026-4048

Bentham Science Publishers

Access to resources Recommend Favorite

Structure-Based Approach for the Discovery of Novel Selective Estrogen Receptor Modulators

By  

Current Medicinal Chemistry, Vol. 18, Iss. 8, 2011-03 ,pp. : 1188-1194

Bentham Science Publishers

Access to resources Recommend Favorite

Structure-Based Virtual Screening: Identification of Novel CB2 Receptor Ligands

By  

Letters in Drug Design & Discovery, Vol. 4, Iss. 1, 2007-01 ,pp. : 15-19

Bentham Science Publishers

Access to resources Recommend Favorite